Teva, Cephalon Can't Upend €60M Fine In Pay-For-Delay Case
Europe's top court on Thursday upheld a fine of €60.5 million ($70.1 million) imposed on Teva and its now-subsidiary Cephalon, ruling that the pay-for-delay settlement they signed restricted competition by keeping...To view the full article, register now.
Already a subscriber? Click here to view full article